Lyra Therapeutics, Inc.LYRANASDAQ
Loading
Asset Growth Under PressureDecelerating
Percentile Rank8
Year-over-Year Change
Year-over-year total asset growth rate
Latest
-16.86%
↓ 240% vs avg
Percentile
P8
Near historical low
Streak
1 qtr
Consecutive declineDecelerating
Average
12.02%
Historical baseline
| Period | Value |
|---|---|
| Q3 2025 | -16.86% |
| Q2 2025 | -6.65% |
| Q1 2025 | -15.12% |
| Q4 2024 | -15.76% |
| Q3 2024 | -16.73% |
| Q2 2024 | -33.17% |
| Q1 2024 | -0.75% |
| Q4 2023 | 18.27% |
| Q3 2023 | -4.06% |
| Q2 2023 | 33.88% |
| Q1 2023 | -14.64% |
| Q4 2022 | -7.95% |
| Q3 2022 | -8.13% |
| Q2 2022 | 174.65% |
| Q1 2022 | -13.71% |
| Q4 2021 | -19.03% |
| Q3 2021 | -11.23% |
| Q2 2021 | 4.68% |
| Q1 2021 | -9.79% |
| Q4 2020 | -7.44% |
| Q3 2020 | -5.82% |
| Q2 2020 | 127.45% |
| Q1 2020 | 172.45% |
| Q4 2019 | 0.00% |
| Q3 2019 | 0.00% |
| Q2 2019 | 0.00% |
| Q1 2019 | 0.00% |